All individual trials at Millendo Therapeutics SAS

1 out of 1

100.0%

Status	Sponsor	Trial ID	Title	Completion date	Days overdue
reported	Millendo Therapeutics SAS	NCT03790865	A Phase 2b/3 Study to Evaluate the Safety, Tolerability, and Effects of Livoletide (AZP-531), an Unacylated Ghrelin Analogue, on Food-related Behaviors in Patients With Prader-Willi Syndrome	2020-02-26

Download this data